Cargando…
A Recombinant MVA-Based RSV Vaccine Induces T-Cell and Antibody Responses That Cooperate in the Protection Against RSV Infection
Respiratory syncytial virus (RSV) causes a respiratory disease with a potentially fatal outcome especially in infants and elderly individuals. Several vaccines failed in pivotal clinical trials, and to date, no vaccine against RSV has been licensed. We have developed an RSV vaccine based on the reco...
Autores principales: | Endt, Kathrin, Wollmann, Yvonne, Haug, Jana, Bernig, Constanze, Feigl, Markus, Heiseke, Alexander, Kalla, Markus, Hochrein, Hubertus, Suter, Mark, Chaplin, Paul, Volkmann, Ariane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238321/ https://www.ncbi.nlm.nih.gov/pubmed/35774800 http://dx.doi.org/10.3389/fimmu.2022.841471 |
Ejemplares similares
-
Preclinical development of a first-in-class vaccine encoding HER2, Brachyury and CD40L for antibody enhanced tumor eradication
por: Hinterberger, Maria, et al.
Publicado: (2023) -
Genetic Adjuvantation of Recombinant MVA with CD40L Potentiates CD8 T Cell Mediated Immunity
por: Lauterbach, Henning, et al.
Publicado: (2013) -
Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults
por: Green, C A, et al.
Publicado: (2015) -
A Monovalent and Trivalent MVA-Based Vaccine Completely Protects Mice Against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenge
por: Henning, Lisa, et al.
Publicado: (2021) -
Is it RSV?
por: Ambrose, Christopher S.
Publicado: (2018)